Intellectual Property India Publishes Patent Application for 'Immunoglobulin Single Variable Domains Targeting T Cell Receptor' Filed by Ablynx Nv; and Sanofi

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517000916 A) filed by Ablynx Nv; and Sanofi, Zwijnaarde, Belgium, on Jan. 4, for 'immunoglobulin single variable domains targeting t cell receptor.'

Inventor(s) include Dullaers, Melissa; Neyt, Katrijn; Roobrouck, Annelies; Staelens, Stephanie; Steffensen, Soren; Van Belle, Tom; Van Hoorick, Diane; and Verhelst, Judith.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "The present technology provides immunoglobulin single variable domains (ISVDs) binding both the constant domain of a human T cell receptor (TCR) on a T cell and the constant doma...